Lecozotan

DB12540InvestigationalSmall molecule

Lecozotan has been used in trials studying the treatment of Alzheimer Disease.

Chemical structure of Lecozotan
Formula / weight
C28H29N5O3 · 483.572 g/mol (avg)

Resolves to

Compound
UNII48854OTZ5ECAS434283-16-6ChEMBLCHEMBL372205PubChem10116877
Structure
InChIKeyNRPQELCNMADTOZ-OAQYLSRUSA-NSMILESC[C@H](CN(C(=O)C1=CC=C(C=C1)C#N)C1=CC=CC=N1)N1CCN(CC1)C1=CC=CC2=C1OCCO2
Targets
P08908HTR1A

What you can answer from here — as of April 23, 2025

2Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
5Clinical trialsPhase, status and sponsor resolved per trial
Sign in
4+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Lecozotan, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In